Nanosphere achieved record revenues for the third quarter of 2015 of $4.9 million compared to $3.7 million in the third quarter of 2014. This 33% year-over-year revenue growth for the quarter ended September 30, 2015 was driven by our expanding customer base and associated infectious disease microbiology test revenue, which grew more than 69% over Q3 2014. The Company also confirmed full year revenue guidance for 2015 of $18-20 million.
According to their ER 9th november:
- Cash at September 30, 2015 was $16.3 million
- 8,2 million shares
Do the math.
Must be the fear of the RS.
The PR machine to vote yes for a RS is even worse......
VOTE NO management betrayed you.
If you vote yes for a RS the shareprice will decrease another 50% in value within a month.
Sorry folks but I don't sell....you're in this ship with me.
You can't prove that BOLD statement.
The only reason you're here is to bash ans scare some retail investors.
do your dd
I did....sec filing two monts ago Kopp bought a lot of shares at $1.03
Youi bashers are so silly.